Recap: AcelRx Pharmaceuticals Q1 Earnings

AcelRx Pharmaceuticals ACRX reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.

AcelRx Pharmaceuticals beat estimated earnings by 3.85%, reporting an EPS of $-0.75 versus an estimate of $-0.78.

Revenue was down $442 thousand from the same period last year.

Last quarter the company missed on EPS by $0.49 which was followed by a 6.0% drop in the share price the next day.

Here's a look at AcelRx Pharmaceuticals's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	-0.51	-1.20	-1.4	-1.2
EPS Actual	-1	-0.94	-1.2	-1.2
Revenue Estimate	4.50M	620K	550K	550K
Revenue Actual	252K	507K	570K	442K

To track all earnings releases for AcelRx Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.